Physician profile
Aimee Cm Jacobs
NPI 1306008461
$3,812.23
in general payments reported to CMS, 2019-2025
30 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $631 · 2021: $750 · 2022: $802 · 2023: $635 · 2024: $209 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $700.73 | 2019-2024 | |
| Astellas Pharma US INC | $504.75 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $280.46 | 2019-2025 | Slynd |
| Pfizer INC. | $261.54 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $241.06 | 2021-2025 | |
| Therapeuticsmd, INC. | $229.07 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $190.03 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $127.97 | 2019-2021 | |
| Evofem Biosciences, INC. | $121.70 | 2020-2025 | Solosec, Phexx, Phexxi |
| Coopersurgical, INC. | $118.15 | 2019-2023 | Paragard T 380a, Mara Console |
| Hologic Sales and Service, LLC | $117.90 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Allergan, INC. | $91.10 | 2019-2020 | |
| Organon LLC | $87.04 | 2021-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $85.75 | 2019-2020 | |
| Myovant Sciences INC. | $84.73 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $81.84 | 2019-2023 | Evenity, Prolia |
| Lupin INC. | $73.00 | 2019-2020 | |
| Avion Pharmaceuticals | $72.78 | 2019-2022 | |
| Millicent US INC | $60.09 | 2019-2024 | Intrarosa, Femring |
| Duchesnay USA Incorporated | $39.44 | 2019 | |
| Agile Therapeutics, INC. | $37.23 | 2021 | |
| Sage Therapeutics, LLC | $34.48 | 2022-2023 | |
| Becton, Dickinson and Company | $29.95 | 2019 | |
| Mylan Pharmaceuticals INC. | $26.90 | 2021 | |
| Heron Therapeutics, INC. | $25.62 | 2022 | |
| Urovant Sciences INC | $21.11 | 2022 | |
| Medtronic, INC. | $19.76 | 2024 | Ligasure |
| Exact Sciences Corporation | $18.59 | 2023 | Cologuard Collection Kit |
| Mycovia Pharmaceuticals, INC. | $15.75 | 2023 | Vivjoa |
| Aspira Women'S Health INC | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.